Cisbio to Support Drug Discovery Customers in Asia through New Technical Support and Service Lab

Cisbio Bioassays has opened a new technical support and service laboratory in Shanghai, China in order to support customers with local training and services. This will support customers in the world's fastest emerging pharmaceutical and biotechnology markets.

This new HTRF demo lab enables Cisbio Bioassays to provide enhanced drug discovery services to its pharmaceutical, CRO and academic laboratory customers in China and surrounding areas. Services include seminars on the principle of HTRF technology, custom labeling and assay development, troubleshooting and problem solving, particularly in the areas of G-Protein Coupled Receptor (GPCR) and kinase investigation.

“Developing assays locally, with locally-produced antibodies, minimizes the logistical hurdles researchers would otherwise face during assay development when they must outsource to third parties in the U.S. or Europe,” said Dr. Bing Xie, director, Asia PacRim, Cisbio Bioassays. “Our new HTRF demo lab will eliminate this problematic for our Chinese customers and enable them, in particular ones who do not have appropriate readers, to better understand HTRF technology and develop their own assays through an accelerated access to our platform.”

“Our second step in China marks an important milestone in confirming our mission to be a best-in-class service- and customer-oriented company in every major market,” said François Degorce, director of marketing for Cisbio Bioassays. “Our Shanghai-based HTRF demo lab now enables us to better deploy our HTRF technology platform with top-notch partners in the area, and provide the same caliber services to our new customers in Asia as we already do in the U.S., in Europe and in Japan.”